An Integrated AI‐PBPK Platform for Predicting Drug In Vivo Fate and Tissue Distribution in Human and Inter‐Species Extrapolation

基于生理学的药代动力学模型 药代动力学 药品 药物开发 药理学 体内 药物发现 化学 分配系数 分布(数学) 计算生物学 医学 色谱法 生物 数学 生物技术 生物化学 数学分析
作者
Wei Wang,Nannan Wang,Yiyang Wu,Zhuyifan Ye,Liang Yu Zhao,Xianfeng Chen,Defang Ouyang
出处
期刊:Clinical Pharmacology & Therapeutics [Wiley]
卷期号:118 (4): 865-875 被引量:23
标识
DOI:10.1002/cpt.3732
摘要

Optimal pharmacokinetic (PK) profile, including tissue distribution, is pivotal for a drug achieving success in clinical trials. Traditionally, PK estimation in early drug development has relied on extensive in vitro and in vivo testing to assess drug-like properties, a process that is not only costly and time-consuming but also limited in its ability to evaluate the synergistic effects of multiple properties. This study aims to develop an integrated artificial intelligence (AI) and physiologically based pharmacokinetic (PBPK) platform to rapidly estimate drug in vivo fate based solely on molecular structures. The AI models were trained to predict eight types of key properties (solubility, pKa values, crystal density, intrinsic dissolution rate, apparent permeability, protein unbound fraction, plasma clearance, and tissue partition coefficients for 15 organs), from which the PBPK model forecasted PK curves without further training. The AI-PBPK approach was validated against human PK data of 71 intravenous and 606 oral administrations collected from the PK-DB database. The results were robust, with most of the AUC predictions falling within two and threefold error ranges. The AI-PBPK model also accurately predicted drug organ selectivity, and for drugs exhibiting high plasma clearance, predictions were optimized through an inter-species extrapolation approach. This study illustrates that the developed modeling strategy adeptly addresses pivotal PK challenges in drug discovery and aligns with contemporary drug development processes. The modeling system can guide candidate selection, advancing more drugs with favorable PK profiles into clinical trials, thereby significantly enhancing the efficiency of drug development.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
科目三的应助被MiyaGuo采纳,获得10
2秒前
哈妮s完成签到,获得积分10
2秒前
Dreamer发布了新的文献求助10
2秒前
科研通AI6.2的应助被Frank采纳,获得10
2秒前
热情松鼠完成签到,获得积分20
3秒前
4秒前
辛勤怜寒完成签到 ,获得积分10
5秒前
hzzzzz发布了新的文献求助10
5秒前
6秒前
友好的冰巧完成签到,获得积分10
7秒前
7秒前
lmy的应助被xxdwyd采纳,获得10
8秒前
科研通AI6.3的应助被tlc_191026采纳,获得10
8秒前
xx发布了新的文献求助10
8秒前
8秒前
8秒前
9秒前
9秒前
9秒前
10秒前
坦率恶天完成签到,获得积分10
11秒前
111发布了新的文献求助10
11秒前
ding的应助被六六大顺采纳,获得10
11秒前
Olive发布了新的文献求助10
12秒前
13秒前
郑睿涛发布了新的文献求助10
13秒前
13秒前
13秒前
14秒前
14秒前
科研通AI2S的应助被牧百川采纳,获得10
14秒前
科小研发布了新的文献求助10
14秒前
14秒前
冷冷子发布了新的文献求助10
15秒前
热情松鼠发布了新的文献求助10
15秒前
yzh发布了新的文献求助30
16秒前
无极微光的应助被曲昊采纳,获得20
17秒前
好好完成签到,获得积分10
17秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183508
求助须知:如何正确求助?哪些是违规求助? 9572862
关于积分的说明 21827639
捐赠科研通 7780681
什么是DOI,文献DOI怎么找? 3434016
关于科研通互助平台的介绍 2558189
邀请新用户注册赠送积分活动 2480405